|
MedChemExpress
pladienolide b Pladienolide B, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pladienolide+b/Pladienolide+B/pm42994428-1111-248-250 Average 94 stars, based on 1 article reviews
pladienolide b - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
pladienolide b Pladienolide B, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pladienolide+b/Pladienolide+B/pm42870295-51-4-6 Average 93 stars, based on 1 article reviews
pladienolide b - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Tocris
nab Nab, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pladienolide+b/Pladienolide+B/pmc13752276-491-14-15 Average 93 stars, based on 1 article reviews
nab - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Eisai Inc
natural product pladienolide b Natural Product Pladienolide B, supplied by Eisai Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pladienolide+b/b+natural+pladienolide+product/pmc13031079-378-3-0 Average 86 stars, based on 1 article reviews
natural product pladienolide b - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
dmso ![]() Dmso, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pladienolide+b/Pladienolide+B/bio_rxiv__64898__2026__02__11__705284-251-12-7 Average 93 stars, based on 1 article reviews
dmso - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Journal: bioRxiv
Article Title: The splicing paralogues SNRPB and SNRPN control differential metabolic states
doi: 10.64898/2026.02.11.705284
Figure Lengend Snippet: (a, b, c, d, e, f, h, i, j) Cropped immunoblots of SNRPB - and SNRPN -cells under various conditions. RNA Pol2, PCNA, GAPDH and Coomassie serve as loading controls. HA-antibody shows overall protein stability differences. Monoclonal SmB/B’/N antibody (clone 12F5) shows detection differences for SNRPN under certain conditions. All experiments were performed at least twice with similar results. For control conditions, the solvent (DMSO, Ethanol, Water) in which the inhibitors are dissolved were added to the media. (a) Truncation mutant of SNRPB - amino acids 1-190 versus 1-231 (full-length) (b) SNRPB/N mutants encoding only amino acids 190 until C-terminal end. (c) SNRPB/N -cells treated 27 hours with 5 μM of PRMT4/CARM1 (left) or 6 days with 10 μM of PRMT5 inhibitor (right). (d) SNRPB/N -cells treated with translation inhibitors Cycloheximide (CHX, 4 hours, 100 μg/mL) or Puromycin (PURO, 20 μM) (e) SNRPB/N -cells treated with mTOR inhibitor INK128 (320 μM). The pAKT blot serves as a positive control for effective treatment. (f) SNRPB/N -cells treated with splicing inhibitor Pladienolide B (PlaB, 16 hours, 100 nM). Effective treatment was evaluated by RT-qPCR, see Extended Data Fig. 5c. (g) Quantification of post-translational modifications (PTMs) by mass spectrometry, as in , including CHX-treated conditions. The experiment was performed together, so the same datapoints from are also shown here (control condition). Each replicate IP sample was split and digested with either elastase (circles) or trypsin (triangles) to generate peptides for mass spectrometry. (h) SNRPB/N -cells treated with NMD inhibitor hSMGi-11e (24 hours, 0.6 μM). Effective treatment was evaluated by RT-qPCR, see Extended Data Fig. 5i. (i) SNRPB/N -cells grown in regular media (1x), media containing no arginine (left, 0x) or no Lysine (right, 0x) or 10-fold higher arginine (left, 10x) or Lysine (right, 10x) concentrations. Treatment was conducted for 16 hours. (j) SNRPB/N -cells grown in regular media (lane 1), media containing L-Glutamine instead of L-Alanyl-L-Glutamine (lane 2), regular media (lane 3) or regular media with reduced glucose content (lane 4). Treatment was conducted for 16 hours.
Article Snippet: A 1 mM stock of Pladienolide B (
Techniques: Western Blot, Control, Solvent, Mutagenesis, Positive Control, Quantitative RT-PCR, Mass Spectrometry